Thomas Kehrer

3.1k total citations
10 papers, 375 citations indexed

About

Thomas Kehrer is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Thomas Kehrer has authored 10 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Thomas Kehrer's work include SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (2 papers) and Influenza Virus Research Studies (2 papers). Thomas Kehrer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (2 papers) and Influenza Virus Research Studies (2 papers). Thomas Kehrer collaborates with scholars based in United States, Austria and Canada. Thomas Kehrer's co-authors include Adolfo Garcı́a-Sastre, Lisa Miorin, Anil Kumar, Tadashi Makio, Tom C. Hobman, Beatriz M. A. Fontoura, Matthew A. Esparza, Christopher P. Ptak, Hualin Zhong and Yi Ren and has published in prestigious journals such as Journal of Virology, Scientific Reports and Science Advances.

In The Last Decade

Thomas Kehrer

10 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kehrer United States 6 235 153 80 48 37 10 375
Yanxi Ji China 7 234 1.0× 118 0.8× 73 0.9× 54 1.1× 26 0.7× 13 351
Thi Khanh Le France 8 308 1.3× 230 1.5× 37 0.5× 54 1.1× 37 1.0× 11 497
Azra Lari United States 5 250 1.1× 189 1.2× 41 0.5× 45 0.9× 32 0.9× 8 421
Hasan Vatandaslar Switzerland 4 253 1.1× 172 1.1× 33 0.4× 42 0.9× 56 1.5× 5 388
Manuel Hayn Germany 5 406 1.7× 240 1.6× 134 1.7× 57 1.2× 70 1.9× 8 598
Maximilian Hirschenberger Germany 7 439 1.9× 229 1.5× 147 1.8× 58 1.2× 72 1.9× 7 615
Oded Danziger Israel 8 253 1.1× 208 1.4× 119 1.5× 25 0.5× 23 0.6× 9 464
Avery Peace United States 3 222 0.9× 162 1.1× 84 1.1× 26 0.5× 32 0.9× 5 358
Liyang Ma China 9 289 1.2× 200 1.3× 122 1.5× 42 0.9× 11 0.3× 12 569
Yanhua Wang United States 7 161 0.7× 126 0.8× 173 2.2× 70 1.5× 19 0.5× 19 378

Countries citing papers authored by Thomas Kehrer

Since Specialization
Citations

This map shows the geographic impact of Thomas Kehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kehrer more than expected).

Fields of papers citing papers by Thomas Kehrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kehrer. The network helps show where Thomas Kehrer may publish in the future.

Co-authorship network of co-authors of Thomas Kehrer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kehrer. A scholar is included among the top collaborators of Thomas Kehrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kehrer. Thomas Kehrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cohen, Phillip, Oded Danziger, Roosheel S. Patel, et al.. (2023). Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing. Microbiology Spectrum. 11(5). e0077623–e0077623. 4 indexed citations
2.
Ya, Chen, Lewis Kaufman, Kyung Lee, et al.. (2022). SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation. Molecular Therapy. 31(3). 774–787. 17 indexed citations
3.
Silvas, Jesus A., Desarey Morales Vasquez, Jun‐Gyu Park, et al.. (2021). Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. Journal of Virology. 95(17). e0040221–e0040221. 80 indexed citations
4.
Kehrer, Thomas, Adolfo Garcı́a-Sastre, & Lisa Miorin. (2021). Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. Journal of Interferon & Cytokine Research. 41(6). 205–219. 4 indexed citations
5.
Rathnasinghe, Raveen, Mirella Salvatore, Hongyong Zheng, et al.. (2021). Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1. Scientific Reports. 11(1). 22164–22164. 10 indexed citations
6.
Bafna, Khushboo, Kris M. White, Balasubramanian Harish, et al.. (2021). Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture. Cell Reports. 35(7). 109133–109133. 59 indexed citations
7.
Zhang, Ke, Lisa Miorin, Tadashi Makio, et al.. (2021). Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Science Advances. 7(6). 151 indexed citations
8.
Jurczyszak, Denise, Wen Zhang, Sandra Terry, et al.. (2020). HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle. PLoS Pathogens. 16(2). e1008305–e1008305. 43 indexed citations
9.
Keller, R., et al.. (1983). Biosynthesis of proteokeratan sulfate in the bovine cornea. 2) Isolation of subcellular membrane fragments from bovine cornea cells with keratan sulfate synthesizing activity.. PubMed. 364(3). 253–60. 3 indexed citations
10.
Weber, W., Thomas Kehrer, Axel M. Gressner, H. W. Stuhlsatz, & H. Greiling. (1983). Changes in the Catalytic Activities of Proteoglycan-Degrading Lysosomal Enzymes in Parenchymal and Non-Parenchymal Liver Cells and in Serum During the Development of Experimental Liver Fibrosis. Clinical Chemistry and Laboratory Medicine (CCLM). 21(5). 287–294. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanxi Ji Breakdown of academic impact, for papers by Thi Khanh Le Breakdown of academic impact, for papers by Azra Lari Breakdown of academic impact, for papers by Hasan Vatandaslar Breakdown of academic impact, for papers by Manuel Hayn Breakdown of academic impact, for papers by Maximilian Hirschenberger Breakdown of academic impact, for papers by Oded Danziger Breakdown of academic impact, for papers by Avery Peace Breakdown of academic impact, for papers by Liyang Ma Breakdown of academic impact, for papers by Yanhua Wang
Rankless by CCL
2026